赛升药业：第五届董事会第十二次会议决议公告

Group 1 - The core point of the article is that Saiseng Pharmaceutical has announced the approval of a financial assistance extension to its subsidiary Junyuan Pharmaceutical by its fifth board of directors' twelfth meeting [2] Group 2 - The financial assistance is aimed at supporting the operations of Junyuan Pharmaceutical [2] - The decision reflects the company's strategy to ensure the stability and growth of its subsidiary [2] - This move may indicate the company's commitment to maintaining its investment in the pharmaceutical sector [2]